A new study<\/strong> from the University of Nottingham challenges the long-held belief that Paracetamol<\/strong> is a particularly safe pain reliever for older adults. Published in the journal Arthritis Care and Research<\/em>, this research raises significant concerns about the health risks associated with this commonly used medication.<\/p>\n Set against the backdrop of a growing population of older adults, the study highlights the \u00a0health issues\u00a0 that increasingly plague individuals aged 65 and above. \u00a0Paracetamol\u00a0, seen for years as a go-to pain relief option, might not be the panacea it was once believed to be.<\/p>\n Led by Professor Weiya Zhang<\/strong>, the study examined health data from over 580,000 British patients<\/strong> with an average age of 75, collected between 1998 and 2018. Researchers compared 180,483 individuals<\/strong> who had been prescribed Paracetamol multiple times (at least two prescriptions within six months) with 402,478 peers<\/strong> who did not use the medication regularly.<\/p>\n The results are \u00a0alarming\u00a0: long-term use of Paracetamol is associated with an increased risk of \u00a0gastric ulcers, heart failure, hypertension,\u00a0 and \u00a0chronic kidney disease\u00a0. Professor Zhang stated, \u201cDue to its perceived safety, Paracetamol has long been recommended as a first-line treatment for osteoarthritis, especially for older adults who may be at a higher risk for medication-related complications.\u201d<\/p>\n These revelations could have sweeping implications for how chronic pain conditions<\/strong>, like osteoarthritis, are treated. Zhang stresses the importance of reconsidering Paracetamol’s role as a first-line therapy for older patients given its minimal pain-relieving effects and newfound risks.<\/p>\nConcerning Findings on Paracetamol Use<\/h2>\n
Is Paracetamol Still a First-Line Treatment?<\/h2>\n